Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,850.20 +366.27 2.53%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,011.40 -51.05 -1.01%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Kyowa Hakko Kirin Co Ltd

+ Add to Watchlist

4151:JP

1,132 JPY 00.00%

As of 20:49:28 ET on 05/23/2013.

Company Profile for Kyowa Hakko Kirin Co Ltd (4151)

Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.

Contact Information

Kyowa Hakko Kirin Co Ltd

1-6-1 Ohtemachi
Chiyoda-ku
Tokyo, 100-8185
Japan
Phone: 81-3-3282-0007
Fax: 81-3-3284-1968

Key Executives for Kyowa Hakko Kirin Co Ltd (4151)

Nobuo HanaiPresidentYoshiharu FurumotoExecutive Vice President
Hiroyuki KawaiSenior Exec Managing OfficerKazuyoshi TachibanaExecutive Managing Officer/CFO
Fumihiro NishinoExecutive Managing Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil